Literature DB >> 2908302

Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.

H Hashimoto1, M Tanaka, A Kanda, A Akashi.   

Abstract

The present experiments were carried out to examine the vasodilator mechanism(s) of carvedilol by use of pithed spontaneously hypertensive rats (SHR). Animals were pithed and the dose-pressor response curves to various agonists were obtained 0.5 or 1 hour after oral administration of either carvedilol (30 mg/kg), labetalol (60 mg/kg), prazosin (0.1 mg/kg) or hydralazine (3 mg/kg). These doses of drugs caused approximately equihypotensive responses in the conscious state. Carvedilol significantly shifted the dose-pressor response curve to the right for phenylephrine but not for B-HT 920, angiotensin II and vasopressin. Labetalol and prazosin also significantly shifted the dose-response curve to the right for phenylephrine but not for angiotensin II. The rank order of inhibitory action on the phenylephrine response was prazosin greater than labetalol greater than carvedilol. In addition, carvedilol produced a slight but significant inhibition of the pressor responses to serotonin (5-hydroxytryptamine), which was nearly identical in magnitude to that seen with hydralazine. These results suggest that the vasodilator action of carvedilol is mainly attributed to alpha 1-adrenoceptor blockade, although additional non-adrenergic mechanism(s) of action cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908302     DOI: 10.2165/00003495-198800366-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  16 in total

1.  The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.

Authors:  T Ogihara; M Ikeda; Y Goto; K Yoshinaga; Y Kumahara; O Iimura; M Ishii; E Murakami; T Takeda; T Kokubu
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  Measurement of blood pressure in unanaesthetized rats and mice.

Authors:  M Gerold; H Tschirky
Journal:  Arzneimittelforschung       Date:  1968-10

3.  Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.

Authors:  J C Kaski; L Rodriguez-Plaza; J Brown; A Maseri
Journal:  Am J Cardiol       Date:  1985-07-01       Impact factor: 2.778

4.  Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of alpha 1-adrenoceptor blockade.

Authors:  C Richer; E Scalbert; M P Doussau; P Duhaze; J F Giudicelli
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

Review 5.  Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

Authors:  P Vanhoutte; A Amery; W Birkenhäger; A Breckenridge; F Bühler; A Distler; J Dormandy; A Doyle; E Frohlich; L Hansson
Journal:  Hypertension       Date:  1988-02       Impact factor: 10.190

6.  Clinical pharmacology of carvedilol in normal volunteers.

Authors:  L X Cubeddu; N Fuenmayor; F Varin; V G Villagra; R E Colindres; J R Powell
Journal:  Clin Pharmacol Ther       Date:  1987-01       Impact factor: 6.875

7.  Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.

Authors:  R Eggertsen; R Sivertsson; L Andrén; L Hansson
Journal:  J Hypertens       Date:  1984-10       Impact factor: 4.844

8.  Studies on the mode of vasodilating action of carvedilol.

Authors:  G Sponer; K Strein; B Müller-Beckmann; W Bartsch
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

9.  Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.

Authors:  K Strein; G Sponer; B Müller-Beckmann; W Bartsch
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

10.  Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat.

Authors:  A Pettersson; K Gradin; T Hedner; B Persson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

View more
  3 in total

Review 1.  Antihypertensive profile of carvedilol.

Authors:  W Meyer-Sabellek; B Agrawal
Journal:  Clin Investig       Date:  1992

2.  Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.

Authors:  Y Nagakawa; Y Akedo; S Kaku; H Orimo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.

Authors:  H Seguchi; H Nakamura; N Aosaki; Y Homma; Y Mikami; S Takahashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.